To include your compound in the COVID-19 Resource Center, submit it here.

Generx (Ad5FGF4): Began Phase IIb/III trial

Collateral Therapeutics Inc. (CLTX), San Diego, Calif.
Product:

Read the full 85 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE